[{"id":"2364b1d1-4b96-431d-9e96-81af23651b73","acronym":"","url":"https://clinicaltrials.gov/study/NCT02314156","created_at":"2021-01-18T10:57:39.970Z","updated_at":"2024-07-02T16:35:54.999Z","phase":"Phase 2","brief_title":"Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy","source_id_and_acronym":"NCT02314156","lead_sponsor":"Northwestern University","biomarkers":" ER • BRCA","pipe":" | ","alterations":" BRCA mutation","tags":["ER • BRCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Proellex (telapristone)"],"overall_status":"Completed","enrollment":" Enrollment 67","initiation":"Initiation: 10/01/2015","start_date":" 10/01/2015","primary_txt":" Primary completion: 01/01/2018","primary_completion_date":" 01/01/2018","study_txt":" Completion: 05/01/2021","study_completion_date":" 05/01/2021","last_update_posted":"2023-02-22"}]